The Peptides Pharma Tirzepatide Vial is a lyophilized vial containing 40 mg of Tirzepatide for once-weekly administration. It combines the dual GIP/GLP-1 mechanism of Tirzepatide with the convenience of a lyophilized vial format for reconstitution.
The Tirzepatide Vial is Peptides Pharma's lyophilized vial containing 40 mg of Tirzepatide for once-weekly subcutaneous administration. The prefilled format eliminates dosing calculation or reconstitution, making it the most convenient Tirzepatide delivery system for research.
The standard Tirzepatide Research Vial contains 10 mg for daily dosing over 30 days. The Tirzepatide Vial contains 40 mg in a prefilled single-use format for once-weekly injection. The Tirzepatide Vial delivers a higher per-dose concentration suited to weekly research protocols.
Administered as a once-weekly subcutaneous injection. Remove cap, prime if required, select injection site (abdomen, thigh, or upper arm), and inject. Prefilled design means no reconstitution, no dose dialling, no multi-step preparation.
Contains Tirzepatide manufactured to >99% purity under GMP-certified conditions. Each production batch independently tested by HPLC and mass spectrometry. Certificates of Analysis available for verification.
Store refrigerated at 2-8°C, away from direct light. Do not freeze. Each vial is individually sealed and should remain in packaging until use. Single-use — no between-dose storage needed once administered.
Designed for metabolic research protocols requiring once-weekly Tirzepatide administration at 40 mg, aligned with published clinical trial protocols. Peptides Pharma products are for research use only.
Approximately 4 Tirzepatide Vials per month (one per week). Each vial is single-use and contains the full 40 mg weekly dose.
The Tirzepatide Vial delivers a potent dual-receptor agonist typically studied as a standalone compound. Researchers considering combinations should carefully review published interaction data. Research purposes only.
Published clinical trials on Tirzepatide enrolled subjects with BMI 27+ with weight-related comorbidities, or BMI 30+. Peptides Pharma provides this for research context only.
Available for research purchase in the UK. Tirzepatide is a research compound when supplied outside prescribed medical contexts. Peptides Pharma supplies the Tirzepatide Vial strictly for laboratory and research purposes.
Answers to frequently asked questions about BPC-157 peptide research. Learn about purity, storage, administration, and research applications of Peptides Pharma BPC-157 vials.
10 questionsPRODUCTAnswers to common TB-500 research questions. Learn about Thymosin Beta-4, tissue repair mechanisms, storage, purity, and Peptides Pharma's lyophilized vial format.
10 questionsPRODUCTCommon CJC-1295 research questions answered. Learn about GHRH analogue mechanisms, GH stimulation, purity, dosing, and Peptides Pharma's lyophilized vial format.
10 questionsPRODUCTIpamorelin research FAQ. Learn about this selective growth hormone secretagogue, its mechanisms, research applications, purity, and Peptides Pharma's vial system.
10 questionsPRODUCTTirzepatide research FAQ. Learn about dual GIP/GLP-1 agonist mechanisms, metabolic research, purity, dosing, and Peptides Pharma's peptide vial system.
10 questionsPRODUCTGHK-Cu copper peptide FAQ. Learn about collagen synthesis, skin repair mechanisms, anti-aging research, purity, and Peptides Pharma's lyophilized vial format.
10 questionsOur team is here to help. Contact us for expert guidance on peptide research.
